Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, the active ingredient in brand-name Mounjaro and compounded formulations, is a dual GLP-1 and GIP receptor agonist designed to reduce appetite and improve metabolic control. Understanding how long your medication stays stable unopened is essential for managing refills, planning treatment cycles, and maximizing the effectiveness of your personalized weight loss protocol.

Unopened Tirzepatide Pen Stability and Shelf Life

An unopened tirzepatide injection pen retains its full therapeutic strength for 36 months from the date of manufacture when stored at the correct temperature. This extended shelf life allows patients to build a small supply without worrying about medication degradation. The stability data comes from rigorous pharmaceutical testing conducted during drug development and applies equally to brand medications and those compounded by licensed 503A pharmacies.

Temperature control is the primary factor determining how long your unopened pen remains safe and effective. Tirzepatide must be stored in a refrigerator maintained between 36°F and 46°F—typical household refrigerator temperature. Exposure to room temperature, heat, or freezing temperatures can shorten shelf life and reduce potency, potentially compromising your weight loss outcomes.

Storage Requirements That Keep Your Tirzepatide Fresh

Proper refrigeration is non-negotiable for unopened tirzepatide pens. Place your medication on a shelf inside the refrigerator rather than in the door, where temperature fluctuations from repeated opening are more pronounced. Never store tirzepatide in the freezer or expose it to direct sunlight, as both conditions can damage the peptide molecule and render it ineffective.

If your unopened pen accidentally freezes, do not use it. Frozen tirzepatide may appear normal but has likely lost potency. Similarly, pens left at room temperature for extended periods should be discarded rather than risk reduced effectiveness. When traveling, use an insulated medication cooler with ice packs to maintain the correct temperature range during transport.

What Happens After You Open Your Tirzepatide Pen

Once you open and use your tirzepatide pen for the first injection, the remaining medication in that pen must be used within 28 days, even if it remains refrigerated. After opening, the sterile seal is broken, which shortens the usable window significantly compared to the 36-month unopened shelf life. Most patients using a standard tirzepatide protocol will complete their pen well within this 28-day window.

PlexusDx compounded tirzepatide injections follow the same stability timelines as brand formulations. Your compounding pharmacy includes clear expiration labels and usage instructions with each shipment. Keeping detailed records of your opening dates ensures you never accidentally use expired medication and helps coordinate seamless refills before your current pen approaches its usage limit.

Optimizing Your Refill Schedule with PlexusDx

PlexusDx compounded tirzepatide injection therapy starts at $289/mo (or $249/mo on the 6-month plan) with a flat-rate pricing model, meaning your dose can increase without your monthly cost increasing. This straightforward pricing structure makes it easier to plan ahead and coordinate refills based on your actual usage rate rather than worrying about cost escalations. Your dose may need to go up. Your price won't.

To prevent gaps in your weight loss treatment and avoid wasting unopened pens past their expiration date, coordinate with your PlexusDx care team to time refills according to your injection schedule. If you're uncertain about how quickly you'll use an unopened pen, discuss this with your provider—they can adjust shipment frequency to match your protocol. PlexusDx serves all 50 states with no insurance requirement and accepts HSA and FSA funds, making it convenient to maintain consistent supply.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How can I tell if my unopened tirzepatide pen has expired?

Check the expiration date printed on the pen's label by the manufacturer or compounding pharmacy. An unopened pen stored correctly in the refrigerator remains good until that date. If you cannot read the date or the pen has been stored outside a refrigerator, discard it to ensure medication safety.

Does compounded tirzepatide from PlexusDx have the same shelf life as Mounjaro?

Yes. PlexusDx compounded tirzepatide is manufactured by licensed 503A compounding pharmacies and follows the same 36-month unopened stability timeline as brand Mounjaro when stored between 36°F and 46°F. Each shipment includes an expiration date specific to that compound batch.

What is the cost difference between tirzepatide injection and oral tirzepatide?

PlexusDx compounded tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan), while oral tirzepatide begins at $349/mo (or $279/mo on the 6-month plan). Both options feature flat monthly pricing regardless of dose adjustments. Many patients prefer the injection form for superior appetite-suppression outcomes in weight loss protocols.

Is it safe to travel with unopened tirzepatide pens?

Yes, you can travel with unopened tirzepatide pens as long as you maintain refrigeration using an insulated cooler with ice packs. TSA permits refrigerated medications in checked and carry-on luggage. Inform security that you're traveling with a medical necessity injection if requested.

How does PlexusDx's Precision Peptide Genetic Test help with tirzepatide outcomes?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), and GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves